Samsca is a medicine for treating abnormally low levels of sodium in the blood in adults with a condition called ‘syndrome of inappropriate antidiuretic hormone secretion’ (SIADH). In SIADH, an excessive amount of the hormone vasopressin makes the patient produce less urine and thereby retain more water in the body, which dilutes the concentration of sodium in the blood. Samsca contains the active substance tolvaptan.
Therapeutic Indication
### Therapeutic indication Treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (SIADH).
Therapeutic Area (MeSH)
N/AATC Code
C03XA01
ATC Item
tolvaptan
Pharmacotherapeutic Group
Diuretics
Active Substance (Summary)
INN / Common Names
N/AEMA Name
Samsca
Medicine Name
Samsca
Aliases
N/ANo risk management plan link.
